參考資料
1.       Swanson JM, Kraemer HC, Hinshaw SP, et al. J Am Acad Child Adolesc Psychiatry 2001;40(2):168-179.
2.       CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.
3.       Krause J, et al. Dialogues Clin Neurosci. 2006;8(1):29-36.
4.       National Institute for Health and Excellence. Attention Deficit Hyperactivity Disorder: diagnosis and management. NICE Guideline NG87; 2018.
5.       Wolraich ML, et al. Pediatrics. 2019;144(4):e20192528.
6.       Nakao T, et al. Am J Psychiatry 2011;168(11):1154-1163.
7.        Baweja R, et al. Paediatr Drugs. 2015;17(6):459-477.

以上資料由受訪者提供
此專欄由武田藥品全力支持
C-ANPROM/HK/Vyv/0044(07/2021)

1 2 3 4